Stockreport

Recursion: Path Forward For REC-994 Remains Despite Mixed Response [Seeking Alpha]

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF Terry Chrisomalis Investing Group Leader Follow Summary Recursion Pharmaceuticals, Inc.'s REC-994 was able to show positive safety/tolerability data for the tre [Read more]